Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Activation of invariant natural killer T cells stimulates adipose tissue remodeling via adipocyte death and birth in obesity
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management
The glucagon component increases your metabolic rate and promotes the breakdown of stored fat for energy
They are also FDA-approved, a fact which validates the fact that these substances are proven to be safe for their intended purpose as facial fillers
Approval (2017) Ozempic: Frequently Asked Questions | Ozempic (semaglutide) injection Wegovy: How to Use the Wegovy Pen | Wegovy (semaglutide) Injection 2.4 mg Influence of Buffering Capacity, pH, and Temperature on the Stability of Semaglutide: A Preformulation Study Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) Oral Semaglutide Versus Subcutaneous Liraglutide And Placebo In Type 2 Diabetes (PIONEER 4): A Randomised, Double-Blind, Phase 3a Trial
US$ 23.72
![Tirzepatide vs. Semaglutide: Which Weight Loss Drug Works Better? [May 2025 NEJM Study Explained]](https://belite.com/wp-content/uploads/2025/06/July-2025-Blog-Post-Belite.png)
US$ 26.51
US$ 29.75
